Cited by 582Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis MechanismsInflammatory Biomarkers in Disease Prognosis

The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.

The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate

Open access

Caine, Graham J, Stonelake, Paul S, Lip, Gregory Y H, Kehoe, Sean T·2002·Neoplasia

DOI 10.1038/sj.neo.7900263PMC PMC1550339

Open this paper in CoChat — free account

Abstract

A hypercoagulable or prothrombotic state of malignancy occurs due to the ability of tumor cells to activate the coagulation system. It has been estimated that hypercoagulation accounts for a significant percentage of mortality and morbidity in cancer patients. Prothrombotic factors in cancer include the ability of tumor cells to produce and secrete procoagulant/fibrinolytic substances and inflammatory cytokines, and the physical interaction between tumor cell and blood (monocytes, platelets, neutrophils) or vascular cells. Other mechanisms of thrombus promotion in malignancy include nonspecific factors such as the generation of acute phase reactants and necrosis (i.e., inflammation), abnormal protein metabolism (i.e., paraproteinemia), and hemodynamic compromise (i.e., stasis). In addition, anticancer therapy (i.e., surgery/chemotherapy/hormone therapy) may significantly increase the risk of thromboembolic events by similar mechanisms, e.g., procoagulant release, endothelial damage, or stimulation of tissue factor production by host cells. However, not all of the mechanisms for the production of a hypercoagulable state of cancer are entirely understood. In this review, we attempt to describe what is currently accepted about the pathophysiology of the hypercoagulable state of cancer. We also discuss whether or not to screen patients with idiopathic deep venous thrombosis for an underlying malignancy, and whether this would be beneficial to patients. It is hoped that a better understanding of these mechanisms will ultimately lead to the development of more targeted treatment to prevent thromboembolic complications in cancer patients. It is also hoped that antithrombotic strategies may also have a positive effect on the process of tumor growth and dissemination.

Integrity signals

Registry

Crossref · 10.1038/sj.neo.7900263

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,368
Prognosis of Cancers Associated with Venous Thromboembolism
Sørensen, H. T., Mellemkjær, L., Olsen, J. H., & Baron, J. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432504 · Cited by 1,628
A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
Fisher, B., Costantino, J., Redmond, C. K., POISSON, R., Bowman, D., Couture, J., Dimitrov, N. V., Wolmark, N., Wickerham, D. L., Fisher, E. R., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200802 · Cited by 1,466
Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W. C., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,059
Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data
Levitan, N. I., Dowlati, A., Remick, S. C., Tahsildar, H. I., Sivinski, L. D., Beyth, R. J., & Rimm, A. A. (1999) · Medicine · doi:10.1097/00005792-199909000-00001 · Cited by 891
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.
Clauss, M. A., Gerlach, M. L., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y.-C. E., Olander, J. V., Connolly, D. T., & Stern, D. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.6.1535 · Cited by 831
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
Hull, R. D., Raskob, G. E., Pineo, G. F., Green, D., Trowbridge, A. A., Elliott, C. G., Lerner, R. G., Hall, J. H., Sparling, T. G., Brettell, H. R., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261502 · Cited by 689
Activation of blood coagulation in cancer: Trousseau's syndrome revisited
Rickles, F., & Edwards, R. (1983) · Blood · doi:10.1182/blood.v62.1.14.bloodjournal62114 · Cited by 680
Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer
Prandoni, P., Lensing, A. W. A., Buller, H. R., Cogo, A., Prins, M. H., Cattelan, A. M., Cuppini, S., Noventa, F., & ten Cate, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210153271604 · Cited by 671
Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone
Folkman, J., Langer, R., Linhardt, R. J., Haudenschild, C. C., & Taylor, S. (1983) · Science · doi:10.1126/science.6192498 · Cited by 619

Show all 125 references

Sorted by citations

Items 201–300 of 582

Increased Risk of Venous Thromboembolism in Women with Uterine Leiomyoma: A Nationwide, Population-Based Case-Control Study.
Huang, H.-K., Kor, C., Chen, C.-P., Chen, H.-T., Yang, P.-T., Tsai, C.-D., & Huang, C.-H. (2018) · Europe PMC (PubMed Central) · doi:10.6515/acs.201801_34(1).20170901b · Cited by 15
Inferior vena cava filter placement in the gynecologic oncology patient: A 15-year institutional experience
Dewdney, S. B., Benn, T. E., Rimel, B. J., Gao, F., Saad, N. E. A., Vedantham, S., Mutch, D. G., & Zighelboim, I. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.01.004 · Cited by 15
Gastrointestinal bleeding: imaging and interventions in cancer patients
Wang, M. X., Guccione, J., Korivi, B. R., Abdelsalam, M. E., Klimkowski, S., Soliman, M., Shalaby, A. S., & Elsayes, K. M. (2022) · British Journal of Radiology · doi:10.1259/bjr.20211158 · Cited by 14
Ascites microenvironment conditions the peritoneal pre-metastatic niche to promote the implantation of ovarian tumor spheroids: Involvement of fibrinogen/fibrin and αV and α5β1 integrins
Laurent-Issartel, C., Landras, A., Agniel, R., Giffard, F., Blanc‐Fournier, C., Silva, E. C. D., Habes, C., Leroy‐Dudal, J., Carreiras, F., & Kellouche, S. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114155 · Cited by 14
Genome-Wide Association Studies of Chemotherapeutic Toxicities: Genomics of Inequality
Mapes, B. L., Charif, O. E., Al-Sawwaf, S., & Dolan, M. E. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0429 · Cited by 14
Lessons from Hippocrates: Time to Change the Cancer Paradigm
Galmarini, C. M. (2020) · International Journal of Chronic Diseases · doi:10.1155/2020/4715426 · Cited by 15
Thrombin-Activatable Fibrinolysis Inhibitor in Breast Cancer Patients
Kaftan, O., Kasapoğlu, B., Köroğlu, M., KOŞAR, A., & Yalçın, K. S. (2011) · Medical Principles and Practice · doi:10.1159/000324547 · Cited by 14
New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism
den Exter, P. L., Kooiman, J., van der Hulle, T., & Huisman, M. V. (2013) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2013.07.004 · Cited by 14
Perioperative Deep Vein Thrombosis Risk Stratification: A Comparative Analysis of Free and Pedicled Flap Patients
Sinha, S., Puram, S. V., Sethi, R. K. V., Goyal, N., Emerick, K. S., Lin, D. T., Durand, M. L., & Deschler, D. G. (2016) · Otolaryngology · doi:10.1177/0194599816667399 · Cited by 14
Circulating Biomarkers for Response Prediction of Rectal Cancer to Neoadjuvant Chemoradiotherapy
Bedin, C., Crotti, S., D’Angelo, E., DaRonco, S., Pucciarelli, S., & Agostini, M. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190507084839 · Cited by 14
Paracrine production of IL-6 promotes a hypercoagulable state in pancreatic cancer.
Wang, S., Du, L., Chen, H., Zhang, X., Chen, B., & Yang, L. (2021) · PubMed Central · Cited by 14
Thrombotic Complications in Gliomas
Czap, A. L., Becker, A., & Wen, P. Y. (2019) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0039-1687892 · Cited by 14
Increased procoagulant activity of red blood cells in the presence of cisplatin
Lu, C., Yu, H., Hou, J., & Zhou, J. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200809020-00004 · Cited by 14
Mechanisms and Neuroimaging Patterns of Hypereosinophilia-Related Ischemic Stroke: A Narrative Review through Three Cases
Cioclu, M. C., Cavallieri, F., Napoli, M., Moratti, C., Pascarella, R., Valzania, F., & Zedde, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195595 · Cited by 13
In Vivo MR Imaging of Fibrin in a Neuroblastoma Tumor Model by Means of a Targeting Gd-Containing Peptide
Chaabane, L., Tei, L., Miragoli, L., Lattuada, L., von Wronski, M., Uggeri, F., Lorusso, V., & Aime, S. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0846-4 · Cited by 13
Description of Venous Thromboembolism in Hospitalized Patients With Metastatic Cancer: A National Sample
Mohammed, K. A., Hinyard, L., Schoen, M. W., Geneus, C. J., Armbrecht, E. S., Buckhold, F. R., & Burroughs, T. E. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.7037 · Cited by 13
Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges
Farge, D., & Frère, C. (2019) · F1000Research · doi:10.12688/f1000research.18673.1 · Cited by 13
Predicting the risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma
Serag, W. M., Mohammed, B. S. E., Mohamed, M. M., & Eysa, B. E. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04677 · Cited by 13
Association between fatty liver index and blood coagulation markers: a population-based study
Morcillo, M. I., Freuer, D., Peters, A., Heier, M., Teupser, D., Meisinger, C., & Linseisen, J. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01854-8 · Cited by 13
Prognostic significance of the absolute monocyte counts in lung cancer patients with venous thromboembolism
Go, S., Kim, R. B., Song, H., Kang, M. H., Lee, U. S., Choi, H. J., Jo, W., Lee, S. J., Cho, Y. J., Jeong, Y. Y., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3475-2 · Cited by 13
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score–matched analysis
Liang, Y.-J., Tang, L., Sun, X.-S., Fan, Y.-Y., Yan, J., Du, Y., Guo, S.-S., Liu, L., Xie, H., Liu, S.-L., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-5213-9 · Cited by 13
Cancer-Associated Thrombosis~!2009-11-10~!2009-12-11~!2010-02-22~!
Karimi, M., & Cohan, N. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004020078 · Cited by 13
Analysis and variability of TGFbeta measurements in cancer patients with skeletal metastases.
O'Brien, P. J., Ramanathan, R., Yingling, J. M., Baselga, J. M., Rothenberg, M. L., Carducci, M., Daly, T. M., Adcock, D. M., & Lahn, M. (2008) · PubMed Central · Cited by 13
Cerebral Venous Thrombosis in the Setting of Malignancy: Case Report and Review of the Literature
Logothetis, C., & Pizanis, C. (2020) · Case Reports in Hematology · doi:10.1155/2020/8849252 · Cited by 13
The effects of preloading infusion with hydroxyethyl starch 200/0.5 or 130/0.4 solution on hypercoagulability and excessive platelet activation of patients with colon cancer
Liang, H., Yang, C., Li, H., Wen, X., Zhou, Q., & Gu, M.-N. (2010) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e328337551f · Cited by 13
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance
Imberti, D., Cimminiello, C., Nisio, M. D., Marietta, M., Friz, H. P., & Ageno, W. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1496238 · Cited by 12
Retinal vein thrombosis and risk of occult cancer: A nationwide cohort study
Hansen, A. T., Veres, K., Prandoni, P., Adelborg, K., & Sørensen, H. T. (2018) · Cancer Medicine · doi:10.1002/cam4.1803 · Cited by 12
Tamoxifen induces hypercoagulation and alterations in ERα and ERβ dependent on breast cancer sub-phenotype ex vivo
Pather, K., & Augustine, T. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-75779-y · Cited by 12
Safety of catheter ablation for atrial fibrillation in patients with cancer: a nationwide cohort study
Thotamgari, S. R., Sheth, A. R., Patel, H., Sandhyavenu, H., Patel, B. A., Grewal, U. S., Bhuiyan, M. A. N., Dani, S. S., & Dominic, P. S. (2023) · Postgraduate Medicine · doi:10.1080/00325481.2023.2218188 · Cited by 12
Endovascular stenting for the management of port-a-cath associated superior vena cava syndrome
Kostopoulou, V., Tsiatas, M. L., Kelekis, D. A., Dimopoulos, M. A., & PAPADIMITRIOU, C. A. (2008) · Emergency Radiology · doi:10.1007/s10140-008-0714-5 · Cited by 12
Previous malignancy is an independent predictor of follow‐up mortality after percutaneous treatment of mitral valve regurgitation by means of MitraClip
Öner, A. Ö., İnce, H., Paranskaya, L., Schröder, G., Sherif, M., Thiele, O., Neuhausen-Abramkina, A., Kische, S., Ortak, J., & D’Ancona, G. (2016) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12239 · Cited by 12
Massive tumor embolism in the abdominal aorta from pulmonary squamous cell carcinoma: Case report and review of the literature
Ohshima, K., Tsujii, Y., Sakai, K., Oku, H., & Morii, E. (2017) · Pathology International · doi:10.1111/pin.12554 · Cited by 12
Increased risk of arterial thromboembolism in older men with breast cancer
Reiner, A. S., Navi, B. B., DeAngelis, L. M., & Panageas, K. S. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4433-z · Cited by 12
Non-specific chest pain and subsequent serious cardiovascular readmissions
Kwok, C. S., Brown, D., Spall, H. G. C. V., Walsh, M. N., Bharadwaj, A. S., Parwani, P. J., Potts, J. E., Loke, Y. K., Martin, G. P., Kontopantelis, E., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.04.001 · Cited by 12
Metabolic crosstalk between platelets and cancer: Mechanisms, functions, and therapeutic potential
Chen, Z., Lin, X., Yu, Y., Zhang, S., & Xue, R. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.02.001 · Cited by 12
Stromal fibrin shapes immune infiltration landscape of pancreatic ductal adenocarcinoma
Karim, M., Hasan, M. M., Kim, S. H., Azam, Z., Wahab, R., Islam, T., Alam, F., Kim, Y.-J., Bae, D., Roy, S., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123280 · Cited by 11
Prothrombotic genotypes and risk of venous thromboembolism in occult cancer
Skille, H., Paulsen, B., Hveem, K., Severinsen, M. T., Gabrielsen, M. E., Kristensen, S. R., Næss, I. A., Hindberg, K., Tjønneland, A. M., Brækkan, S. K., et al. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2021.06.019 · Cited by 11
Early Outcomes of Percutaneous Coronary Intervention in Patients with Cancer: A Systematic Review and Meta-analysis
Balakrishna, A. M., Ismayl, M., Srinivasamurthy, R., Gowda, R. M., & Aboeata, A. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101305 · Cited by 11
Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Nonvalvular Atrial Fibrillation and Cancer: A Systematic Review and Network Meta-analysis
Barbarawi, M., Barbarawi, O., Corcoran, J., Obeidat, K., Al‐Abdouh, A., Mhanna, M., kasasbeh, M. A., & Pickett, C. C. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101346 · Cited by 11
Short‐ and Long‐Term Mortality for Patients With and Without a Cancer Diagnosis Following Pulmonary Embolism in Denmark, 2000 to 2020: A Nationwide Study
Madsen, S. F., Christensen, D. M., Strange, J. E., Nouhravesh, N., Kümler, T., Gislason, G., Lamberts, M., & Sindet‐Pedersen, C. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030191 · Cited by 11
Plasma Fibrinogen Predicts the Prognosis of Bladder Cancer Patients After Radical Cystectomy
Yang, S., Guan, H., Wang, S., Wu, H., Sun, W., Chen, Z., & Li, Q. (2020) · Cancer Management and Research · doi:10.2147/cmar.s269244 · Cited by 11
Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma
Mewhort‐Buist, T. A., Liaw, P. C., Patel, S. B., Atkinson, H., Berry, L. R., & Chan, A. K. C. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2007.12.003 · Cited by 11
Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor
Bravo, M. L., Pinto, M. P., González, I., Oliva, B., Kato, S., Cuello, M. A., Lange, C. A., & Owen, G. I. (2014) · Endocrine · doi:10.1007/s12020-014-0288-9 · Cited by 11
Hemolytic Anemia and Metastatic Carcinoma: Case Report and Literature Review
Pendse, A. A., Edgerly, C. H., & Fedoriw, Y. D. (2014) · Laboratory Medicine · doi:10.1309/lm6fenwrxx5grwbt · Cited by 11
Treatment of EGFR mutation-positive non–small cell lung cancer complicated by Trousseau syndrome with gefitinib followed by osimertinib: a case report
Nonagase, Y., Takeda, M., Tanaka, K., Hayashi, H., Iwasa, T., & Nakagawa, K. (2018) · Oncotarget · doi:10.18632/oncotarget.25687 · Cited by 11
Two cases of acute myocardial infarction during combined chemotherapy in young patients with testicular cancer
Kawano, N., Yamaguchi, K., Niki, T., Yamamoto, T., Iwase, T., Taketani, Y., Ise, T., Yamada, H., Soeki, T., Wakatsuki, T., et al. (2013) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2013.02.009 · Cited by 10
Systemic thromboembolism from a misdiagnosed non‑bacterial thrombotic endocarditis in a patient with lung cancer: A case report
Perrone, F., Biagi, A., Facchinetti, F., Bozzetti, F., Ramelli, A., Vezzani, A., Manca, T., Gnetti, L., Majori, M., Alfieri, V., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.12056 · Cited by 10
A Propensity-Matched Analysis of the Postoperative Venous Thromboembolism Rate After Pancreatoduodenectomy Based on Operative Approach
Hue, J. J., Elshami, M., Beckman, M. J., Driedger, M. R., Rothermel, L. D., Hardacre, J. M., Ammori, J. B., Winter, J. M., & Ocuin, L. M. (2021) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-05191-y · Cited by 10
Central retinal vein occlusion in the setting of fibroblast growth factor receptor inhibition
Foulsham, W., Edghill, B., Canestraro, O. D. J., Makker, V., Konner, J. A., Abramson, D. H., & Francis, J. H. (2022) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2022.101657 · Cited by 10
The association between cancer diagnosis, care, and outcomes in 1 million patients hospitalized for acute pulmonary embolism
Mai, A. S., Matetić, A., Elgendy, I. Y., Lopez-Mattei, J. C., Kotronias, R. A., Sun, L. Y., Yong, J. H., Bagur, R., Spall, H. G. C. V., & Mamas, M. A. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.09.049 · Cited by 10
Portal vein thrombosis in patients with hepatocellular carcinoma and early cirrhosis – prevalence and risk factors
Siddiqui, M. T. U.-H., Fareed, G., Khan, M. R., Riaz, A., & Hamid, S. S. (2023) · ecancermedicalscience · doi:10.3332/ecancer.2023.1581 · Cited by 10
Thromboembolic Events in the Cancer Patient
Lin, J. T. (2003) · Journal of Women s Health · doi:10.1089/154099903768248249 · Cited by 10
Biomarkers of Cancer-Associated Thromboembolism
Mahajan, A., & Wun, T. (2019) · Cancer treatment and research · doi:10.1007/978-3-030-20315-3_5 · Cited by 10
Cryptogenic Stroke
Amatangelo, M. P. (2020) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2019.11.008 · Cited by 10
Portomesenteric vein thrombosis after gastric surgery
Han, J.-W., Kong, S., Shin, C., Min, S., Min, S., Kim, T. H., Yang, J., Oh, S., Suh, Y., Lee, H., et al. (2015) · Gastric Cancer · doi:10.1007/s10120-015-0562-4 · Cited by 10
Perioperative Blood Biomarkers of Infectious and Non-Infectious Postoperative Pulmonary Complications: A Narrative Review
Gigliotti, S., Guerriero, G., Mazza, G., Garofalo, E., Pavia, G., Amaddeo, A., Rizzuto, A., Marascio, N., Quirino, A., Longhini, F., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020699 · Cited by 11
The Role of New Oral Anticoagulants (NOACs) in Cancer Patients
Ravikumar, R., Lim, C. S., & Davies, A. H. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_112 · Cited by 9
Analysis of haemostasis biomarkers in patients with advanced stage lung cancer during hypofractionated radiotherapy treatment
Wolny-Rokicka, E. I., Brzeźniakiewicz‐Janus, K., Wydmański, J., Tukiendorf, A., & Zembroń-Łacny, A. (2018) · Journal of International Medical Research · doi:10.1177/0300060517750976 · Cited by 9
Freezing Oocytes or Embryos After Controlled Ovarian Hyperstimulation in Cancer Patients: The State of the Art
Bénard, J., Duros, S., Hachem, H. E., Sonigo, C., Sifer, C., & Grynberg, M. (2016) · Future Oncology · doi:10.2217/fon-2016-0095 · Cited by 9
Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysis
Young, K., Paz-Ares, L. G., Thatcher, N., Spigel, D. R., Shahidi, J., Soldatenkova, V., Grau, G., Kurek, R., & Shepherd, F. A. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.05.004 · Cited by 9
Ischemic Stroke in Patients with Cancer: A Retrospective Cross-Sectional Study
Moțățăianu, A., Maier, S., Andone, S. R., Bărcuţean, L., Şerban, G. M., Bajkó, Z., & Bălașa, A. F. (2021) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2021-0002 · Cited by 9
Limited malignancy screening of patients with idiopathic venous thromboembolism
Semb, V. B., & Tveit, A. (2014) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.13.0310 · Cited by 9
Multiple embolic cerebral infarcts as the first manifestation of metastatic ovarian cancer
Bond, L. M., & Skrobo, D. (2015) · BMJ Case Reports · doi:10.1136/bcr-2015-211521 · Cited by 9
Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study
Fawzy, M. S., Mohammed, E. A.-M., Ahmed, A., & Fakhr-Eldeen, A. (2015) · Meta Gene · doi:10.1016/j.mgene.2015.03.004 · Cited by 9
Inferior Vena Cava Filters in the Cancer Patient: Current Use and Indications
Getzen, T. M., & Rectenwald, J. E. (2006) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2006.0073 · Cited by 9
Rapid occurrence of left ventricular thrombus associated with platinum-based chemotherapy plus cetuximab for the treatment of metastatic squamous cell carcinoma of the head and neck: A case report
Ikeda, A., Yamachika, E., Mizutani, M., Matsubara, M., Moritani, N. H., Nakatsuji, K., & Iida, S. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1393 · Cited by 9
Platelet adhesion in breast cancer
Caine, G. J., Nadar, S. K., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2004) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200408000-00012 · Cited by 9
Self-citation
Síndromes paraneoplásicos en tumores gastrointestinales. Revisión de tema
Páez, L. R. R., Yurgaky, J. M., Regino, W. O., & Faizal, M. (2017) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.155 · Cited by 9
Anticoagulation is Not Mandatory After Stenting for Malignant Superior Vena Cava Syndrome
Thony, F., Fagedet, D., Michoud, M., Moro‐Sibilot, D., Ferretti, G., & Rodiere, M. (2014) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-014-0902-5 · Cited by 9
Treatment of coronary artery disease in cancer survivors
Hess, C. N., & Roe, M. T. (2016) · Coronary Artery Disease · doi:10.1097/mca.0000000000000444 · Cited by 9
Previous History of Breast Cancer Increases Rates of Pulmonary Embolism and Costs after Total Knee Arthroplasty: An Evaluation of 185,114 Matched Patients
Rosas, S., Luo, T. D., Jinnah, A. H., Marquez-Lara, A. J., Roche, M. W., & Emory, C. L. (2018) · The Journal of Knee Surgery · doi:10.1055/s-0038-1641155 · Cited by 8
The Value of Detecting Pathological Changes During Clot Formation in Early Disease Treatment-Naïve Breast Cancer Patients
Goncalves, J. N., de Waal, G. M., Page, M. J., Venter, C., Roberts, T. J., Holst, F., Pretorius, E., & Bester, J. (2021) · Microscopy and Microanalysis · doi:10.1017/s1431927621000015 · Cited by 8
Analysis of Relationships Between Prethrombotic States and Cervical Cancer
Sun, Y.-H., Cui, L., Chen, J., Wang, M., Liu, J., Liu, X., & Huang, X. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.14.6163 · Cited by 8
Routine Hemostasis and Hemogram Parameters
Zhu, Y., Feng, T., Zhou, X., Hu, X., Ding, J., Zhu, W., Qian, D., & Sun, Y. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.186637 · Cited by 8
Pulmonary thromboembolism secondary to pelvic thrombosis related to giant ovarian tumor
Amadasi, A., Andreola, S., Bianchi, M., Boracchi, M., Gentile, G., Maciocco, F., Marchesi, M., & Zoja, R. (2019) · Autopsy and Case Reports · doi:10.4322/acr.2018.061 · Cited by 8
Extended Venous Thromboembolism Prophylaxis after Abdominopelvic Cancer Surgery: A Retrospective Review
Laureano, M., Ebraheem, M. S., & Crowther, M. A. (2019) · Current Oncology · doi:10.3747/co.26.4339 · Cited by 8
Diagnostic utility and clinical implication of late gadolinium enhancement cardiac magnetic resonance for detection of catheter associated right atrial thrombus
Plodkowski, A. J., Chan, A. T., Gupta, D., Lakhman, Y., Kukar, N., Kim, J. J., Pérez-Johnston, R., Ginsberg, M. S., Steingart, R. M., & Weinsaft, J. W. (2020) · Clinical Imaging · doi:10.1016/j.clinimag.2020.01.021 · Cited by 8
Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation
Krishan, S., Munir, M. B., Khan, M. Z., Al-Juhaishi, T. M. S., Nipp, R. D., DeSimone, C. V., Deshmukh, A. J., Stavrakis, S., Barac, A., & Asad, Z. U. A. (2023) · EP Europace · doi:10.1093/europace/euad129 · Cited by 8
Optimal activated clotting time during peripheral artery endovascular procedures: cutting the gordian knot
Patrone, L., Pasqui, E., Sheahan, K. P., de DONATO, G., & Thulasidasan, N. (2023) · The Journal of Cardiovascular Surgery · doi:10.23736/s0021-9509.23.12703-0 · Cited by 8
Multiple Hypercoagulability Disorders at Presentation of Non-Small-Cell Lung Cancer
Lee, J. M., Lim, J. H., Kim, J. S., Park, J. S., Memon, A., Lee, S., Nam, H., Cho, J. H., Kwak, S.-M., Lee, H. L., et al. (2014) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2014.77.1.34 · Cited by 8
Sepsis increases perioperative metastases in a murine model
Tai, L., Ananth, A. A., Seth, R., Alkayyal, A. A., Zhang, J., de Souza, C. T., Staibano, P., Kennedy, M. A., & Auer, R. C. (2018) · BMC Cancer · doi:10.1186/s12885-018-4173-4 · Cited by 8
Clinical Features of Trousseau Syndrome With Cerebral Infarction as the Initial Manifestation
Ren, R., Yan, H., Gui, Y., Zhao, J., Wang, H., Ji, D., Song, J., & Zhang, P. (2020) · The Neurologist · doi:10.1097/nrl.0000000000000275 · Cited by 8
Prognostic significance of pretreatment plasma D-dimer levels in patients with spinal chordoma: a retrospective cohort study
Li, B., Zhang, H., Zhou, P., Yang, J., Wei, H., Yang, X., Yang, C. Z., Wu, Z., & Xiao, J. (2019) · European Spine Journal · doi:10.1007/s00586-018-05872-4 · Cited by 8
Epidemiology, Pathophysiology, and Management of Cancer-Associated Ischemic Stroke
Ryan, D., Dargham, T. B., Ikramuddin, S. S., Shekhar, S., Sengupta, S., & Feng, W. (2024) · Cancers · doi:10.3390/cancers16234016 · Cited by 7
Cancer-associated ischemic stroke: current knowledge and future directions
Lun, R., & Siegal, D. M. (2024) · Bleeding Thrombosis and Vascular Biology · doi:10.4081/btvb.2024.117 · Cited by 7
Biology of renal cancer tumor thrombus - towards the personalized approach
Sharma, S. K., Kunc, M., Czapliński, M., Łyzińska, W., Pęksa, R., Qu, L., Radziszewski, P., & Zapała, Ł. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104731 · Cited by 7
Epónimos relacionados con la pancreatología. Sus protagonistas
Navarro, S. (2016) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2016.03.008 · Cited by 7
Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015
Alam, A. U., Karkhaneh, M., Sun, H., & Wu, C. M. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.12.021 · Cited by 7
Effect of occult malignancy on femoropopliteal bypass graft thrombosis
Png, C. Y. M., Wang, L. J., DeCarlo, C. S., Latz, C. A., Sumpio, B. J., Weinberg, I., Eagleton, M. J., & Dua, A. (2021) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2021.01.058 · Cited by 7
Characteristics of cerebral sinus venous thrombosis in men
Simaan, N. M., Filioglo, A., Honig, A., Aladdin, S., Cohen, J. E., & Leker, R. R. (2021) · Acta Neurologica Scandinavica · doi:10.1111/ane.13454 · Cited by 7
Chest Pain in the Cancer Patient
Tyebally, S. M., Ghose, A., Chen, D. H., Abiodun, A., & Ghosh, A. K. (2022) · European Cardiology Review · doi:10.15420/ecr.2021.45 · Cited by 7
Diagnosis of portal vein thrombosis in cirrhotic patients with and without hepatocellular carcinoma
Serag, W. M., & Eysa, B. E. (2022) · Egyptian Liver Journal · doi:10.1186/s43066-022-00201-3 · Cited by 7
Cancer incidence and mortality after a first-ever venous thrombosis: a cohort study in northern Sweden
Hägg, L., Ehrs, F., Lind, M. M., & Johansson, M. (2024) · Thrombosis Journal · doi:10.1186/s12959-024-00646-z · Cited by 7
Nonbacterial Thrombotic Endocarditis Leading to Acute Heart Failure due to Aortic Stenosis in a Patient with Lung Cancer
Taniyama, D., Yamamoto, R., Kawasaki, M., Kamata, H., Miyamoto, K., Mashimo, S., & Sakamaki, F. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.0123 · Cited by 7
Malignancy and Hemostasis
Idle, M. R., Claiborne, S. T., Patel, K., & Kademani, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-71240-6_7 · Cited by 7
Can Biomarkers of Coagulation, Platelet Activation, and Inflammation Predict Venous Thromboembolism in Patients with Haematological Malignancies?
Elmoamly, S., Mattar, M., Yacoub, M. F., & Afif, A. (2019) · Acta Haematologica · doi:10.1159/000496914 · Cited by 7
Thrombophlebitis Migrans (Trousseau Syndrome) in Pancreatic Adenocarcinoma: An Autopsy Report
Stoyanov, G. S., Dzhenkov, D. L., & Tzaneva, M. A. (2019) · Cureus · doi:10.7759/cureus.5528 · Cited by 7
A Kunitz-type inhibitor from tick salivary glands: A promising novel antitumor drug candidate
Lobba, A. R. M., Flores, M. P. A., Fessel, M. R., Buri, M. V., Oliveira, D. S., Gomes, R. N., Cunegundes, P. S., DeOcesano-Pereira, C., Cinel, V. D. P., & Chudzinski-Tavassi, A. M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.936107 · Cited by 6
Hypercoagulability State Combined with Post-Treatment Hypofibrinolysis in Invasive Breast Cancer: A Seven-Year Follow-Up Evaluating Disease-Free and Overall Survival
Wrzeszcz, K., Rhone, P., Kwiatkowska, K., & Ruszkowska-Ciastek, B. (2023) · Life · doi:10.3390/life13051106 · Cited by 6
Comparative analysis of the aberrant immunophenotype and clinical characteristics in dogs with lymphoma: a study of 27 cases
Bae, H., Kim, S., & Yu, D. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1254458 · Cited by 6

Authors: Caine, G. J., Stonelake, P. S., Lip, G. Y. H., & Kehoe, S. T.
Affiliations: Birmingham City Hospital (GB)
Birmingham Women's Hospital (GB)
ORCID: Lip, Gregory Y H
Kehoe, Sean T
Venue: Neoplasia
Publisher: Elsevier BV
Published: 2002
Volume: 4
Issue: 6
Pages: 465-473
ISSN: 1476-5586 (ISSN-L)
1522-8002
DOI: 10.1038/sj.neo.7900263
PMC: PMC1550339
OpenAlex: W2120304210
Cited by: 576
References: 125
Citations by year: 2026: 25 · 2025: 45 · 2024: 30 · 2023: 48 · 2022: 43 · 2021: 36 · 2020: 35 · 2019: 47 · 2018: 49 · 2017: 28 · 2016: 27 · 2015: 25 · 2014: 26 · 2013: 13 · 2012: 7
FWCI: 5.03
Type: journal article
Language: en
Open access: gold
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neoplasia (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Topics: Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords: cancer-associated thrombosis, hypercoagulability, procoagulant factors, fibrinolysis, inflammatory cytokines, tissue factor, antithrombotic therapy, venous thromboembolism
MeSH terms: Antineoplastic Agents, Blood Coagulation, Blood Coagulation Factors, Cell Communication, Humans, Neoplasms, Cytokines, Thrombophilia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks